Related Experiment Video
Updated: Nov 2, 2025

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.3K
Olfactory Dysfunction in Neurodegenerative Disease
Israel Saramago1, Ana M Franceschi2
1University of North Carolina at Chapel Hill, Chapel Hill, NC.
Topics in Magnetic Resonance Imaging : TMRI
|June 7, 2021
Summary
Olfactory dysfunction is an early sign of dementia and neurodegenerative diseases. Understanding smell physiology aids in diagnosing these conditions using clinical and advanced imaging findings.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Olfactory dysfunction is a common early symptom in various neurodegenerative diseases.
- Understanding the physiology of smell is crucial for diagnosing neurological disorders.
- Smell impairment can precede cognitive decline in conditions like Alzheimer's and Parkinson's disease.
Purpose of the Study:
- To review the clinical and advanced imaging findings associated with olfactory dysfunction in neurodegenerative disorders.
- To highlight the role of smell impairment as an early diagnostic biomarker.
- To provide a comprehensive overview for clinicians and researchers.
Main Methods:
- Review of characteristic clinical presentations of olfactory dysfunction.
- Analysis of advanced neuroimaging techniques (e.g., MRI, PET) in patients with smell deficits.
- Correlation of olfactory findings with established diagnostic criteria for neurodegenerative diseases.
Main Results:
- Olfactory dysfunction presents characteristically across different neurodegenerative conditions.
- Advanced imaging reveals specific patterns of brain changes associated with smell impairment.
- Early olfactory deficits are frequently observed in patients with dementia and Parkinson's disease.
Conclusions:
- Olfactory dysfunction is a significant indicator of underlying neurodegenerative processes.
- Integrating clinical smell assessments with advanced imaging enhances diagnostic accuracy.
- Further research into smell-based biomarkers can improve early detection and management of neurodegenerative diseases.
Related Concept Videos
Olfactory Receptors: Location and Structure
10.0K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.0K
Olfaction
46.4K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
46.4K
Physiology of Smell and Olfactory Pathway
10.3K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
10.3K
Alzheimer's Disease: Overview
941
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
941
Parkinson's Disease: Overview
1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Neural Regulation
40.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K

